🟢 Harrow Health is trading 5.4% up today as it rebounds from recent weakness with no clear catalyst identified

Harrow Health is trading at $39.49 (5.4% up) in after-hours trading, rebounding from recent weakness observed over the past week.

• No fresh company-specific headlines, earnings releases, FDA actions, or major analyst calls have been linked to the move.
• The strength appears to be opportunistic buying following a broader biotech risk-off pullback rather than a clearly defined catalyst.
• Broader market indices remain relatively calm, suggesting the move is driven by technical positioning after the recent sector-wide dip.